U.S. COVID-19 Vaccine Supply Chain Suppliers Facilities: Johnson & Johnson's Janssen COVID-19 Vaccine

Identified United States COVID-19 Vaccine manufacturing facilities and suppliers

Source: From Lab to Vaccine Vial: The Historic Manufacturing Journey of Johnson & Johnson's Janssen COVID-19 Vaccine. Retrieved March 8, 2021. G. R. A. M. (2021, March 23, 2020). Development and Manufacturing Facilities. “Johnson & Johnson on track for 100 million vaccine doses by end of June, bolstering US supply”, Retrieved, Jan. 31st, 2021. Brody, B. September 10, 2020 – “4 High-Tech Tools Johnson & Johnson Is Using to Get Products to You During the Pandemic”, Retrieved, March 8th 2021. Press Release - G. R. A. M. (2021, March 23, 2020). Development and Manufacturing Facilities Retrieved March 8th, 2021. HHS - Biden Administration Announces Historic Manufacturing Collaboration Between Merck and Johnson & Johnson to Expand Production of COVID-19 Vaccines, Retrieved March 8, 2021. Moderna Press Release, Jan. 27th 2021, Moderna confirms Discussions with U.S. Government for Additional 100 Million Doses of the Moderna COVID-19 Vaccine, Retrieved, Feb. 1st, 2021. USITC (2020). COVID-19 Related Goods: The U.S. Industry, Market, Trade, and Supply Chain Challenges. Dec. 2020. U.S. Census Population Estimates 2019, Retrieved – Jan. 29th 2021. Pfizer, Press Release, Dec. 23, 2020, “Pfizer and BioNTech to Supply the U.S. with 100 Million Additional Doses of COVID-19 Vaccine”, Retrieved, Jan. 31st, 2021. Pfizer, Press Release, Dec. 23, 2020, “Pfizer and BioNTech to Supply the U.S. with 100 Million Additional Doses of COVID-19 Vaccine”, Retrieved, Jan. 31st, 2021. U.S. Department of Health & Human Services – Operation Warp Speed Logistics - 12/03/2020. Karen Young, Omar Chane, Glenn Hunzinger, and Benjamin Isgur. Sept. 2020, "Developing COVID-19 vaccines may not be enough: Turning vaccines into vaccinations." PwC Health Research Institute. Endo International, “Endo Announces Fill-Finish Manufacturing,” September 25, 2020; Emergent BioSolutions, “Emergent BioSolutions Signs Agreement,” April 23, 2020; Emergent BioSolutions, “Emergent BioSolutions Signs Agreement,” July 27, 2020; Emergent BioSolutions, “Emergent BioSolutions Signs Five-Year Agreement,” July 6, 2020; Catalent, “Moderna and Catalent Announce Collaboration,” June 25, 2020; Catalent, “Catalent Signs Agreement,” August 24, 2020; Inovio, “INOVIO Adds Thermo Fisher Scientific,” September 8, 2020; Novavax, “Novavax Announces Facility Expansion,” November 2, 2020; Blankenship, “Emergent BioSolutions, BARDA Reach,” June 1, 2020; Novavax, “Novavax and FUJIFILM Diosynth,” July 23, 2020; Platoff, “Texas Biotech Facility,” July 27, 2020; Keown, “Federal Government Taps,” July 28, 2020; BioSpace, “Vaxart Announces,” March 18, 2020; Grand River Aseptic Manufacturing, “GRAM Partners,” September 25, 2020; Mullin, “Moderna Picks,” May 1, 2020; Stanton, “Inhouse Manufacturing,” May 19, 2020; Avid Bioservices, “Oragenics Signs Process Development,” August 20, 2020; Catalent, “Arcturus Therapeutics and Catalent,” May 4, 2020; Catalent, “Catalent Signs Agreement,” April 29, 2020; Veleta, “Potential Covid Vaccine,” May 28, 2020; Pfizer, “Scaling Up to Manufacture,” May 5, 2020; Contract Pharma, “Kindred, Vaxart Enter COVID- 19,” May 22, 2020; Ology Bioservices, “U.S. Army Contracting Command,” August 26, 2020; AGC, “AGC Expands Contract,” August 18, 2020; Intelligencer, “Sanofi: COVID-19 Vaccines,” August 4, 2020; GlaxoSmithKline, “GSK Announces Intention,” May 28, 2020; GRAM Website, “Large Scale Filling” (accessed November 15, 2020); Martin, “Inside the Operation Warp Speed Effort,” November 8, 2020; Feingold, “When Vaccine is Ready,” October 2, 2020; Johnson, “A vial, a Vaccine and Hopes,” November 17, 2020; Altimmune, “Altimmune Announces Manufacturing Agreement,” July 22, 2020; Vigene Biosciences, “Vigene Biosciences Secures Institutional,” April 29, 2019; NantKwest, “ImmunityBio & NantKwest Sign,” May 27, 2020; NantKwest, “Form 10-K, March 25, 2020, 8, 114; Medicago, “Medicago Begins Phase I,” July 14, 2020; Medicago Website, “Frequently Asked Questions” (accessed November 18, 2020); CordenPharma, “Core Capabilities” (accessed November 17, 2020); CordenPharma, “Moderna Extends Lipid Supply,” May 28, 2020.; Centaur Biopharmaceutical Services, “cGMP Manufacturing” (accessed November 18, 2020); KindredBiosciences, “Kindred Biosciences Announces Expansion,” October 7, 2020; Catalant, “Catalent Partners with Spincona,” June 10, 2020; Rodriguez, “Novavax COVID-19 Vaccine Receives,” November 10, 2020; Businesswire, “Moderna and Catalent Announce”, June 25, 2020; Stanton, “Inovio’s COVID-19 vaccine,” April 8, 2020; Blakenship, “Inovio Accuses Manfacturing Partner,” June 5, 2020; Sagonowsky, “Moderna has started turning out COVID-19 ,” July 15, 2020; Gilgore, “Novavax’s latest win?,” June 5, 2020; Hargreaves, “Altimmune Partners with Lonza,” BioProcess International, November 16, 2020; Catalent. “Catalent Biologics Invests $50 Million,” September 2, 2020; Keller and Krabbe, “ABQ Plant to Play a Role,” September 18, 2020.